A randomized trial of platelet transfusions over 30 vs 120 minutes: is there an effect on post-transfusion platelet counts?
INTRODUCTION
Infrequent in healthy term newborns, 1 thrombocytopenia is much more common in preterm and sick term newborns. Up to one-third of babies admitted to neonatal intensive care units have been found to have platelet counts o150 000 mm À 3 . 2 The problem is accentuated in extremely low gestational age newborns, up to 73% of whom may be affected. 3 Estimates of neonatal intensive care unit patients receiving platelet transfusions range from 2 to 7%, [4] [5] [6] with the majority of these babies receiving more than one. 7 Little in the way of standardization exists for platelet transfusion techniques, as demonstrated in our own facility 8 as well as internationally. 9 Recently, we conducted a retrospective analysis examining the effect of duration of platelet transfusions on posttransfusion platelet counts. 8 We found some evidence suggestive of more effective transfusions (as demonstrated by higher posttransfusion platelet counts) with shorter transfusion times. On the basis of this observation, we conducted a prospective, randomized study to evaluate post-transfusion platelet counts in thrombocytopenic newborns transfused with standardized volumes of platelet pheresis over two different durations. We tested the hypothesis that shorter duration of platelet transfusion would be more effective in increasing platelet count.
METHODS

Patient population
This study took place in the neonatal intensive care unit at the University of Oklahoma Health Sciences Center from December 2009 to December 2010. Parents of infants who were to receive platelet transfusions were approached for this study. The necessity of the transfusion was left to the clinical judgment of the baby's attending neonatologist; there were no set criteria for platelet transfusions at the time of this study. After the researchers obtained informed consent from the subject's parents, a sealed, opaque envelope containing the results from a randomization scheme (computer-generated and operated by a statistician before the initiation of the study) was opened to determine into which of the two groups the transfusion would fall. Neither of the primary researchers was responsible for the randomization nor did they have prior knowledge of the group assignment.
Babies with multiple congenital anomalies were excluded from this study, as were babies diagnosed with neonatal alloimmune thrombocytopenia. Also, platelet transfusions for babies who developed thrombocytopenia while on extracorporeal life support were not eligible for randomization.
The University of Oklahoma Health Sciences Center institutional review board approved this study. It is registered as NCT00948792 at Clinicaltrials.gov.
Study procedures
Each transfusion was of a standardized volume of 15 ml kg À 1 of noncentrifuged, leukoreduced, irradiated pheresis platelets and was randomized into one of two groups: a 'short' group (in which platelets were given over 30 min) and a 'long' group (in which platelets were given over 2 h). The pheresis platelets were filtered at our blood bank before transfusion. The platelet counts of the units transfused were not statistically different (mean þ s.d. in short vs long group: 3.69 þ 0.49 ( Â 10 11 ) vs 3.62 þ 0.30 ( Â 10 11 ), P ¼ 0.62); these counts were determined within 10 to 16 h of the time of collection.
Platelet counts were measured 30 min and 6 h after the completion of the transfusion. We chose 30 min in order to see the effect of transfusion on platelet count; the 6h timed draw was chosen to assess the stability of 1 the increase in platelets after the transfusion. In other words, although the 6-h platelet level could be reflective of the disease process causing the thrombocytopenia, it also may represent platelet injury during transfusion process. The 30-minute post-transfusion platelet count was the primary end point. We also analyzed our results to assess 'efficacy' of the response to the platelet infusion (defined as an increase in post-transfusion counts of 50 000 mm À 3 per 10 ml kg À 1 of platelet pheresis transfused). 10 Platelets were drawn either from indwelling catheters or via heel puncture. The same method was utilized for each of the salient blood draws for a given transfusion. Platelet counts were determined by the Coulter LH 500 Hematology Analyzer (Beckman Coulter; Brea, CA, USA).
We also collected clinical data including the presumed underlying cause of thrombocytopenia and changes in blood pressure with platelet transfusion.
Statistical analysis
Using a ¼ 0.05 and a power of 0.9, it was determined that in order to show a difference of 20 000 platelets mm À 3 (with a s.d. of 20 000) in posttransfusion rise of blood platelet concentration between the two transfusion times, a total of 44 platelet transfusions needed to be studied; one patient, therefore, could provide data for several transfusions. The figure of 20 000, though arbitrary, is most likely clinically significant. The data were analyzed using parametric (for data with a normal distribution, t test), nonparametric (for skewed data, Wilcoxon rank-sum test) and logistic regression analyses. Pearson's correlation was used to assess the relationship between postmenstrual age (PMA) and changes in platelet count. Results are presented as mean ± s.d. for data with a normal distribution and median (range) for skewed data. A P valueo0.05 is considered statistically significant.
As the design of the study allows for one patient to have multiple transfusions potentially randomized into both groups, we recognized that this may confound the independence of each individual transfusion. To that end, we performed two additional data analyses: an independent sample analysis for the subjects with only one transfusion to detect any difference by group, and a paired samples analysis for subjects with multiple transfusions where the results of the group's transfusions were averaged for each patient and the difference between the two groups was tested.
RESULTS
Twenty-eight babies met the criteria for this study. The parents refused consent for six of these babies. One baby was determined to have neonatal alloimmune thrombocytopenia after his initial platelet transfusion; these data were discounted. In summary, 21 babies had 43 platelet transfusions randomized in this study; the group assignment was carried in each case. Figure 1 details the number of platelet transfusions per participant. The mean ( ± s.d.) gestational age and birth weight of the study population were 29.5 (±4.6) weeks and 1262.1 (±904.9) g, respectively. The mean ( ± s.d.) PMA of the study population at the time of transfusion was 32.3 ± 4.6 weeks. Table 1 shows the demographic information for each group. The presumptive etiologies of the thrombocytopenia necessitating the platelet transfusion are listed in Table 2 . The interval between the initial platelet draw (pretransfusion) and the subsequent transfusion was not different between the two groups (mean intervals: 5.7 h (short) vs 6.9 h (long); P ¼ 0.27). The pretransfusion platelet counts were similar in the two groups (Table 3) .
There was no statistical difference between the two groups in change of platelet counts at 30 min and 6 h after the transfusion (Table 3) . Furthermore, the changes in platelet count from 30 min to 6 h after the transfusion were not statistically different between the two groups ( Table 3) .
The independent samples comparison of the 13 subjects receiving only one platelet transfusion (seven in the short group, The etiologies presented are based on the presumed cause of thrombocytopnia for each transfusion rather than for each subject. The data was highly skewed (degree of skewness 1.7) for the long group and moderately skewed (degree of skewness 0.58) for the short group.
Transfusion duration has no effect on counts DC Dannaway and S Noori six in the long group) did not reveal any significant differences in post-transfusion platelet counts at 30 min (short vs long, 124 vs 125 ( Â 1000 mm ), P ¼ 0.86). The difference between the 30-minute and 6-h post-transfusion platelet counts was also not significantly different (short vs long, À 5.9 vs 11.8 ( Â 1000 mm À 3 ), P ¼ 0.51). Similarly, the paired samples analysis (for the eight subjects with multiple transfusions (median 3, range 2 to 8) where the results of the group's transfusions were averaged for each patient and the difference between the two groups was tested) did not show any significant differences in platelet counts at 30 min (short vs long, 106.9 vs 100.6 ( Â 1000 mm À 3 ), P ¼ 0.83) and at 6 h (99.1 vs 83.4 ( Â 1000 mm À 3 ), P ¼ 0.56), nor was there a significant difference between the two post-transfusion counts (6.4 vs 26.3 ( Â 1000 mm
We utilized univariate logistic regression analysis to determine whether PMA, pretransfusion platelet count, necrotizing enterocolitis (NEC) and sepsis were associated with efficacious transfusion (that is, an increase in post-transfusion counts of 50 000 mm À 3 per 10 ml kg À 1 of platelet pheresis transfused). 10 None of these variables was associated with any significant effect at 30 min (data not shown). However, at 6 h, lower PMA and absence of NEC diagnosis were associated with a higher rate of efficacious transfusion. When adjusted for the other variable, only lower PMA was predictive of efficacious transfusion (PMA (weeks) odds ratio 0.83 (0.70 to 0.99), P ¼ 0.039). In addition, we found that PMA had a weak but significant negative correlation with the change in platelet count with both transfusion times (Figures 2 and 3) . The median mean blood pressures taken before and after the transfusions were not significantly different in each group (short: 46 (33 to 68) vs 44 (28 to 73) mm Hg, P ¼ 0.7; long: 34 (25 to 56) vs 33 (26 to 50) mm Hg, P ¼ 0.9).
Of note, 35 of the 43 transfusions (81.4%) were administered through peripheral intravenous lines. Umbilical venous catheters, other central venous lines and peripherally-inserted central catheters were the means of delivery for 11.6, 4.7 and 2.3% of transfusions, respectively.
DISCUSSION
Our study demonstrates that there is no significant difference between platelet transfusions given over 30 min and 2 h in increasing blood platelet counts at 30 min and 6 h after transfusion. Transfusions over both 30 min and 2 h were well tolerated as evidenced by stable blood pressure.
The observation that several babies received multiple transfusions could lead to suggestions that one particular baby's subsequent transfusions may not qualify as an independent event, especially as it was possible for one baby to have transfusions in both arms of the study. To address this possible bias, additional statistical analyses were performed. The results of these additional analyses did not alter our original conclusions, as none of them showed any statistically significant changes.
Our previous study suggested that babies who received platelets more quickly had higher post-transfusion platelet counts and more efficacious transfusions. 8 That study was limited by its retrospective design, nonstandardized platelet transfusion volumes and absence of standardized platelet count monitoring. To our knowledge, there are no other studies examining the effect of the duration of platelet transfusions on resultant platelet counts.
The general mechanisms of thrombocytopenia in the newborn are decreased platelet production, increased platelet destruction or a combination of the two. It has been suggested that sepsis may reduce platelet counts by both mechanisms.
11 NEC could also be thought to induce thrombocytopenia by multiple pathways, as it often involves a bleeding process. On the other hand, decreased platelet production is the underlying cause of thrombocytopenia in maternal preeclampsia. 12 The number of babies receiving platelets due to thrombocytopenia caused by maternal preeclampsia was seemingly overrepresented in the short transfusion group; however, the low sample size (n ¼ 5) precludes us from offering comment on any effect this may have had. The rate of main causes of thrombocytopenia in our population (that is, sepsis and NEC) were similar in the two groups; therefore, the underlying etiology is unlikely to have had a role in any observations. As we noted in our prior study, 8 the method of delivery (peripheral intravenous lines vs umbilical venous catheters, for example) may also factor into some of the observations made during this study. In this study, the line with the smallest caliber (peripherally inserted central catheter) was used for only one transfusion. Also, platelet counts determined by heel stick could be artificially lowered owing to presence of small clots.
The finding that a baby's response to a platelet transfusion seemed to be inversely related to its PMA was unexpected. The higher circulating blood volume of a more mature infant could partially explain this finding. Interestingly, diagnoses of sepsis or NEC (main underlying causes of thrombocytopenia in our population) did not affect this relationship.
We did not stratify each group based on the etiology of thrombocytopenia as the sample size was small. However, the distribution of the presumed underlying causes of thrombocytopenia was similar between the two groups, with one notable exception: more babies with maternal preeclampsia had transfusions randomized to the short group. Although the sample size of our study was small, the difference between the two groups' response to platelet transfusion was so small that it is unlikely a larger sample size would have altered the results. Indeed, based on our results, in order to demonstrate a statistical difference between the short and long transfusion groups, a sample of 45000 transfusions in each group is needed. Figure 3 . Correlation between the PMA and change in platelet count at 6 h after transfusion (r ¼ À 0.37, P ¼ 0.018).
In summary, we found that the duration of platelet transfusions did not have a significant effect on post-transfusion platelet counts. Platelet transfusions over 30 min and 2 h are both welltolerated by the neonatal intensive care unit population.
